Form 4 for TRAW Traws Pharma, Inc.
Accepted 2025-12-16 00:00:00 ET · period of report 2025-12-12 · accession 0001681955-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-16 | 2025-12-12 | TRAW | Dukes Iain D. | CEO, Dir | A - Grant | $0.00 | +36.9K | 171.1K | +28% | $0 |
| D | 2025-12-16 | 2025-12-12 | TRAW | Dukes Iain D. | CEO, Dir | A - Grant | $0.00 | +147.8K | 147.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-12 | A | A | 36,943 | $0.00 | 171,130 | D | — | — | (F1) Represents an award of restricted stock units that will vest 100% on the first anniversary of the grant date. Each restricted stock unit will convert into shares of common stock on a one-for-one basis. |
| 2 | Derivative | Stock Option (right to purchase) | 2025-12-12 | A | A | 147,771 | $0.00 | 147,771 | D | $2.33 · 2026-12-12 to 2035-12-12 | 147,771 Common Stock | (F2) The options vest 100% on the first anniversary of the grant date. |